Stay updated on Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision metadata was updated from v3.5.3 to v3.5.4, indicating a newer version of the page. This change reflects a backend update rather than a user-facing modification.
    Difference
    0.1%
    Check dated 2026-05-14T22:35:32.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now shows a new site revision tag (v3.5.3) replacing the previous revision (v3.5.2), indicating a small platform update without changes to the study data or presentation.
    Difference
    0.1%
    Check dated 2026-04-30T18:22:10.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.5.2 added. Revision: v3.5.0 removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:09:28.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T20:13:05.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3; core study details appear unchanged.
    Difference
    0.1%
    Check dated 2026-03-11T14:46:35.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    An updated site revision tag (v3.4.2) was added, and an existing government funding status notice (v3.4.1) was removed. The study’s content and data remain unchanged.
    Difference
    0.4%
    Check dated 2026-02-11T02:13:35.000Z thumbnail image

Stay in the know with updates to Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.